文献速递认知障碍与痴呆脑血管病

临床判断的听力损害与神经病理负荷的关联

Clinician-judged hearing impairment and associations with neuropathologic burden.
PubMed 文献 · Neurology · 2020-08-05

研究纳入2755例≥55岁已解剖的NACC数据库参与者,分析临床判断的听力损害与痴呆相关神经病理的关系。结果显示,基线认知正常者中听力损害与更高Braak分期相关(RR 1.33每2级升高,95%CI 1.06-1.66);痴呆患者中听力损害与微梗死正相关(RR 1.18,95%CI 1.00-1.39),与神经炎性斑块密度负相关(RR 0.91每评分升高,95%CI 0.85-0.99)。

要点

  • 基线认知正常者听力损害与神经原纤维缠结负荷增加独立相关
  • 痴呆患者听力损害与微梗死正相关、与神经炎性斑块密度负相关
  • 认知障碍者听力损害发生与皮层Lewy小体相关(RR 1.26,95%CI 1.02-1.55)

核心结论

  • 认知损害前报告的听力损害与神经原纤维缠结负荷增加相关,可能为临床前标志。
  • 认知损害者的听力损害与微梗死及皮层Lewy小体相关,而非典型AD病理。

研究设计与样本

  • 基于NACC数据库的回顾性尸检研究,纳入2755例≥55岁、死亡前2年内至少1次临床评估的参与者。
  • 听力损害由临床医生报告在基线判定,采用logistic回归并计算边际标准化相对风险。

主要发现

  • 听力损害常见,占32%。
  • 基线认知正常者(n=580)中,听力损害与更高Braak分期相关(RR 1.33每2级升高,95%CI 1.06-1.66),与其他病理无显著关联。
  • 痴呆患者(n=2175)中,听力损害与微梗死正相关(RR 1.18,95%CI 1.00-1.39),与神经炎性斑块密度负相关(RR 0.91每评分升高,95%CI 0.85-0.99)。
  • 认知障碍者出现听力损害与皮层Lewy小体相关(RR 1.26,95%CI 1.02-1.55)。

临床怎么用

  • 对认知正常老年人,临床判断的听力损害可提示神经原纤维缠结负荷增加,需关注认知变化。
  • 对痴呆患者,听力损害需综合评估微梗死及Lewy小体病理可能,而非仅归因于AD病理。

局限性

  • 听力损害基于临床医生报告,非听力学检测,可能存在分类偏倚。
  • 为尸检横断面关联分析,不能推断因果关系,结论需重复验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To examine whether neuropathologic burden is associated with hearing impairment. METHODS: We studied 2,755 autopsied participants ≥55 years of age from the National Alzheimer's Coordinating Center database. Participants had at least 1 clinical evaluation at US National Institute on Aging-funded Alzheimer's Disease Center no more than 2 years before death. Patients were classified as hearing impaired by clinician report at baseline. Common dementia neuropathologies included Alzheimer disease pathologic change (Consortium to Establish a Registry for Alzheimer's Disease neuritic plaque density, neurofibrillary degeneration Braak stage), Lewy body disease, gross infarcts, and microinfarcts. Logistic regression models predicted impaired hearing with adjustment for age at death, sex, race, education, center, and follow-up time. Relative risks were calculated with the use of marginal standardization. RESULTS: Impaired hearing was common (32%). In participants who were cognitively normal at baseline (n = 580), impaired hearing was associated with higher Braak stage (relative risk [RR] 1.33 per 2-stage increase, 95% confidence interval [CI] 1.06-1.66) but not other pathologies. In participants with dementia (n = 2,175), impaired hearing was positively associated with microinfarcts (RR 1.18, 95% CI 1.00-1.39) and inversely associated with neuritic plaque density (RR 0.91 per score increase, 95% CI 0.85-0.99). Development of impaired hearing in those with cognitive impairment was associated with neocortical Lewy bodies (1.26, 95% CI 1.02-1.55). CONCLUSIONS: Impaired hearing, reported before the onset of cognitive impairment, was associated with increased neurofibrillary tangle burden. Impaired hearing in those with cognitive impairment was associated with microinfarcts and neocortical Lewy bodies but not typical Alzheimer disease pathologic change. Functional hearing problems may be a preclinical marker of neurofibrillary neurodegeneration, although replication is needed.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Brenowitz WD, Besser LM, Kukull WA, et al. Clinician-judged hearing impairment and associations with neuropathologic burden. Neurology. 2020. PMID: 32759190. doi:10.1212/WNL.0000000000010575

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。